Avigen

About Avigen

Avigen is developing a platform to identify highly effective immune cells for use in cellular immunotherapies. This technology aims to accelerate the development of new therapies by pre-selecting potent cells, reducing risks and streamlining the process.

What does Avigen do?

Avigen is developing a platform to identify highly effective immune cells for use in cellular immunotherapies. This technology aims to accelerate the development of new therapies by pre-selecting potent cells, reducing risks and streamlining the process.

When was Avigen founded?

Avigen was founded in 2025.

How much funding has Avigen raised?

Avigen has raised 387600.

Who founded Avigen?

Avigen was founded by Tobias Gamper.

  • Tobias Gamper - CEO / Co-founder
Founded
2025
Funding
387600
Employees
5 employees
Major Investors
SFC Capital
Looking for specific startups?
Try our free semantic startup search

Avigen

Score: 100/100
AI-Generated Company Overview (experimental) – could contain errors

Executive Summary

Avigen is developing a platform to identify highly effective immune cells for use in cellular immunotherapies. This technology aims to accelerate the development of new therapies by pre-selecting potent cells, reducing risks and streamlining the process.

avigen.co.uk200+
cb
Crunchbase
Founded 2025

Funding

$

Estimated Funding

$387.6K+

Major Investors

SFC Capital

Team (5+)

Tobias Gamper

CEO / Co-founder